Icotrokinra Psoriasis Trial Shows Durable Response
ADULTS with moderate-to-severe plaque psoriasis treated with the oral interleukin-23 (IL-23) receptor inhibitor icotrokinra maintained high rates of skin clearance
ADULTS with moderate-to-severe plaque psoriasis treated with the oral interleukin-23 (IL-23) receptor inhibitor icotrokinra maintained high rates of skin clearance
Only 31 per cent of US voters believe healthcare does a good job of meeting women’s needs, according to a
PLANT-BASED DIETS have been linked to lower cardiovascular risk in people with severe autoimmune diabetes1, according to evidence from the
A screen time app that lets friends cut their phone use together has won the £15,000 top prize in a
A HIGH-RESOLUTION ultrasound scan of the labial salivary glands could offer a non-invasive alternative to biopsy for diagnosing Sjögren’s disease,
Avni Wellness has secured Rs 4 crore, around US$470,000, in seed funding to expand its products and digital commerce capabilities.
Imagion Biosystems (ASX: IBX) has secured firm commitments for AU$3.75 million (US$2.59 million) in new capital following FDA clearance of
AI in paediatric radiology is seeing cautious but growing adoption globally, although its clinical impact remains modest as healthcare organisations
Xella Health has launched what it calls the first AI precision health platform built for the XX chromosome. The company
PLAYING video games is associated with small but consistent improvements in cognitive ability, a large meta-analysis of 133 studies concludes,